Study of AP31969 for atrial fibrillation rhythm control
Part of Heart & circulation clinical trials.
This study tests a new medication, AP31969, to control heart rhythm in people with atrial fibrillation. It compares the drug to a placebo to see if it can reduce how often AF episodes happen over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have atrial fibrillation (AF) that comes and goes or is persistent, and you've had at least one episode that stopped on its own in the last 4 months.
- You are willing to avoid other heart rhythm treatments (like certain medications, cardioversion, or ablation) during the study.
- You are willing to have a small device called a loop recorder placed under your skin to monitor your heart rhythm.
- You have not had an AF ablation other than a specific type called pulmonary vein isolation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial compares two medications that control heart rate, verapamil and metoprolol, taken only when you feel an episode of paroxysmal atrial fibrillation (short, irregular heartbeats). It also tests a smartphone app that helps you manage your condition. The goal is to see if this approach improves symptoms and reduces episodes.
This study tests a new drug called BAY 3670549 to see if it can help convert atrial fibrillation (an irregular heartbeat) back to normal rhythm. You'll receive the study drug or a placebo along with a procedure to restore your heart's normal rhythm, and researchers will monitor how well it works and how safe it is.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.